Sr Director and Team Lead, Regulatory Labelling Strategy and Development, Oncology
Leads a global team responsible for developing and managing regulatory labelling strategies for oncology products across the drug development lifecycle. Ensures compliance with global regulations, collaborates with cross-functional stakeholders in R&D, safety, and commercial teams, and engages with regulatory authorities to shape innovative, patient-focused labelling. Plays a strategic role in governance and policy development within GSK’s oncology portfolio.